SUMMARY
Market access plays a pivotal role for whether pharma companies will get a successful launch of their new medicine or not. This requires a string, cross functional collaboration especially between Commercial, Medical and Market Access.
During this course, you will get an indepth knowledge about the Market Access work including the most important external stakeholders; how you can best contribute to the success; and how you can best plan the collaboration with Market Access, if you work in e.g. Commercial or Medical.
KEYWORDS
- Market Access
- Strategy
- Cross Functional Collaboration
- Danish Medicines Council
- Reimbursement on medicine
- Pricing
- Negotiation
- Health Economics
Hi! Do you need help choosing the right course?
We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com
Course leader(s) & Lecturers
- Anne KolbyeCourse leaderValue Demonstration Manager
Roche A/S - Sune Tüxen JørgensenCourse leaderSquad Lead
Roche A/S - Asger LindvigLecturerDirector
NHTA ApS - Flemming AxelsenLecturerAssociate Director Patient Access
Swedish orphan biovitrum A/S - Uffe PlougLecturerHEOR Manager
UCB Nordic A/S - Peter Bo PoulsenLecturerSr. Market Access Manager
PFIZER ApS
IS THIS COURSE FOR YOU?
Join us if you work e.g. in Market Access, as Medical advisor or in a commercial function.
WHAT YOU WILL LEARN
- You will get an indepth knowledge about the Market Access work and the collaboration between Market Access and especially Commercial and Medical departments.
- You will be introduced to real success and failure cases and the key learnings from these.
- Through case work you will get the opportunity to plan your own market access strategy, to test your ideas and get feedback from the course leaders.
WHAT YOUR COMPANY WILL GET
- An employee, who understands the processes of the market access work and the most important external stakeholders
- An employee, who knows how to plan a market access strategy through cross functional collaboration
Course calendar
DAY 1
- Welcome and introduction to the course
- From traditional functionally divided organization -> cross functional ways of working
- Case: A company’s way through The Medicines Council
- Workshop: Amgros, the health economic analysis, pricing and negotiation
- Recap of the day and take home messages
DAY 2
- Introduction to the day and recap of day 1
- Market access – the company’s most demanding and most cross-functional discipline
- Health economics as a practical tool in grant applications
- What are the processes for vaccine in relation to the national vaccination program with public subsidies
- Pricing in the primary and secondary sector
- Case: Preparation of a Market Access strategy for a primary or secondary sector product (of your choice). Feedback on ideas and approach
- Round-off of the course
Registration
Registration deadline1. Nov 2021
Lersø Parkallé 101
2100 København Ø
Course information
Literature
Prior to the course you will get access to mandatory and optional readings via your personal Atrium log-in.
Please familiarize yourself with the mandatory readings before starting the course. The mandatory readings are also part of the examination syllabus.
You are welcome to send the 2-3 most common misunderstandings, concerns or issues, you experience in the collaboration between Market Access, Commercial and/or Medical. Please click here, fill in the form and submit it.
Examination
There is no examination for this course.
This course is a part of this programme
Our Market Access Programme provides you with in-depth knowledge of the Danish healthcare system and its funding models and stakeholders. Raise your skill level in areas such as public affairs, stakeholder management and health economics by attending the four courses
Read morePharma Consultant Programme
Design a medical training programme that fits your professional interests. Relevant if you work with or advice on drugs, maybe as a professional in sales and marketing, market access or public affairs in the pharma industry
Read moreCourse leader(s)
Roche A/S
Roche A/S
Lecturers
Roche A/S
Roche A/S
NHTA ApS
Swedish orphan biovitrum A/S
UCB Nordic A/S
PFIZER ApS